Overview
Printcare provides printing, packaging and digital media solutions across tea, apparel, FMCG, telecommunications, education and other industries, with operations extending into India and Kenya. Its latest operating result marks a clear deterioration: revenue increased, but profitability weakened sharply and the group remained loss-making.
Price performance
The price sits at 9.3% of its 52-week range, only 6.3% above the low and 36.7% below the high. Recent annualised volatility was 42.6%, 7.5% below its own one-year level, while 20-day average volume was 99.6% above its 60-day average.
Valuation
The dividend yield is 0.0%, and the payout has been declining: dividends per share were LKR 8.00 in FY2022, LKR 5.50 in FY2023 and LKR 2.00 in FY2024. The low book multiple therefore is not supported by a growing income distribution.
News and sentiment
Direct coverage is thin. Two neutral company announcements, dated 2026-03-27 and 2026-04-22, concerned investment in Printcare Digital (Private) Limited; the 90-day news window contains no material articles and no confirmed corporate actions.
Financials
The latest full year produced negative ROE of -10.4% and a net margin of -8.5%, following a 4.8% revenue decline. Owners’ equity was LKR 5.53 billion at the latest quarter-end, down from LKR 6.76 billion at the latest annual comparison, while the reported share count was unchanged at 85.97 million across the latest quarterly periods.
Risks
Manufacturing conditions add pressure through labour shortages and higher energy and input costs. Although market interest rates have eased, fuel-price volatility and higher inflation remain relevant to a cost-sensitive printing and packaging operation.
Outlook
The April company announcement provides no newer operating figures, so the data cannot yet establish whether the investment in Printcare Digital (Private) Limited is improving group profitability. The combination of weaker margins, negative interest cover and sector-wide labour and input-cost pressure leaves the next reported results as the key evidence, rather than the low P/B alone.